CHPFF yields 7.33% · PFE yields 6.13%● Live data
📍 CHPFF pulled ahead of the other in Year 1
Combined, CHPFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHPFF + PFE for your $10,000?
Charoen Pokphand Foods Public Company Limited, together with its subsidiaries, engages in the agro-industrial and integrated food businesses in Thailand and internationally. It operates in two segments, Livestock Business and Aquaculture Business. The company produces and sells swine, chicken, cattle, duck, shrimp, and fish feeds; and breeds and farms swine, broiler, layer, duck, and shrimp. It is also involved in the animal feed raw materials distribution, investment and international trading, food products wholesale and retail, property investment, property lease-out, shrimp hatchery, and animal feedmill businesses. In addition, the company produces and distributes elite seeds, pet food, chlortetracycline, aquatic feed, sea food products, as well as motorcycle carburetor, auto parts, and plastic; and imports and distributes eggs, processed meat, milk products, and ready meals. Further, it offers economic and trade consulting, management and advisory, financial guarantee, biological waste management, information technology, food research and development, logistics, and financial services. Additionally, the company engages in the operation of food processing plants, hotels and restaurants, slaughterhouses, and training centers; broiler chicken integration business; provision and development of Asian food products; and swine farm construction activities. It provides its products primarily under the CP and Butcher brands. The company also exports its products. Charoen Pokphand Foods Public Company Limited was incorporated in 1978 and is headquartered in Bangkok, Thailand.
Full CHPFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.